 |
|
Current concepts of neurofibromatosis type 1: pathophysiology and treatment
Jaemin Choi, Sungbin An, So Young Lim
Arch Craniofac Surg. 2022;23(1):6-16. Published online 2022 Feb 20 DOI: https://doi.org/10.7181/acfs.2022.00633
|
|
Citations to this article as recorded by
 Unraveling neuronal and metabolic alterations in neurofibromatosis type 1
Valentina Botero, Seth M. Tomchik
Journal of Neurodevelopmental Disorders.2024;[Epub] CrossRef A rare clinical manifestation of plexiform neurofibroma in the absence of neurofibromatosis-1: a case report
Evance Salvatory Rwomurushaka, Alex Mremi, Atiyya Hussein, Esther Majaliwa, Jay Lodhia
International Journal of Surgery: Global Health.2024;[Epub] CrossRef Multidisciplinary Outpatient Clinic of Neurocutaneous Diseases: Five-year Experience of a Pediatric Tertiary Hospital in Portugal
Mafalda Rebelo, Telma Francisco, Rosário Perry da Câmara, Andreia Pereira, Amets Iraneta, Marta Amorim, Maria João Paiva Lopes, Rita Lopes da Silva, Ana Isabel Cordeiro
Acta Médica Portuguesa.2023;[Epub] CrossRef Targeted Muscle Reinnervation and Regenerative Peripheral Nerve Interfaces for Prophylactic Pain Control in Neurofibromatosis Type 1 Amputees
Ashley Shin, Megan Fracol, Margaret S. Roubaud
Plastic and Reconstructive Surgery - Global Open.2023; 11(11): e5405. CrossRef A Case Report on Smear-Positive Pulmonary Tuberculosis with Neurofibromatosis Type-1
Khushboo Chavda, Smit Mistry, Cyril Sajan
Journal of the Scientific Society.2023; 50(2): 265. CrossRef
|